Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of RAGE in Uremic Vasculopathy of Hemodialyzed Patients
NCT02818465Completed
- Sponsor
- CHU de Reims
- Start
- Mar 2015
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Reims. Primary endpoint: Framingham Risk Score at 12 months. Started Mar 2015; status: completed.
Beyond the preview
Go deeper on NCT02818465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818465.